BEIJING, Nov 5 (Reuters) - Shares of Chinese COVID-19 vaccine developer Clover Biopharmaceuticals Ltd (2197.HK), opens new tab fell as much as 8.7% on its Hong Kong trading debut on Friday after ...

A Chinese biotech has taken up vaccine maker ... the companies announced Monday. The company, Clover Biopharmaceuticals, started working on its vaccine last month, as the outbreak of the virus ...

Hundreds of millions of Covid-19 vaccine doses developed by a Chinese pharmaceutical company ... Chengdu-based vaccine maker Sichuan Clover Biopharmaceuticals, Inc will receive up to US$328 ...

BEIJING: Clover Biopharmaceuticals became the sixth Chinese developer of a potential COVID-19 vaccine to move into human trials on Friday, launching a study in Australia that will test its vaccine ...

SHANGHAI -- China's Clover Biopharmaceuticals is set to debut on the Stock Exchange of Hong Kong on Friday as it races to win regulatory approval and begin shipments of its COVID-19 vaccine.

Chinese telecoms giant Huawei bent over backwards ... spying still saw Huawei banned from the UK's 5G networks. Project Clover aims to convince European lawmakers TikTok is safe.

BEIJING : Chinese COVID-19 vaccine developer Clover Biopharmaceuticals said on Thursday it raised US$240 million in net proceeds in initial public offering (IPO) of shares in Hong Kong.

Rising Chinese-Singapore entertainment group GHY Culture & Media is to acquire majority control of independent Singapore film distributor Clover Films. The move was described as a “strategic ...

Chinese COVID-19 vaccine firm Clover falls on trading debut Open in App ...